JOHN CONNORS: Open Payments
NPI 1477831121 · PASCAGOULA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 47 payments from 12 companies in 2025. Trend: 2023 $16 · 2024 $0 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 15 | $185 |
| ABBVIE INC. | 13 | $160 |
| Corium, LLC | 5 | $111 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Tris Pharma Inc | 2 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $40 |
| Vertical Pharmaceuticals, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: SPRAVATO, VRAYLAR, Azstarys, FANAPT, Auvelity, Dyanavel XR, Qelbree, Relexxii.
Industry payments across MS — which companies pay providers there.
